MERCURY LABORATORIES Financial Statement Analysis
|
||
|
The Revenues of MERCURY LABORATORIES have increased by 30.06% YoY .
The Earnings Per Share (EPS) of MERCURY LABORATORIES has increased by 1.36 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
MERCURY LABORATORIES Last 5 Annual Financial Results
[BOM: 538964]
| Standalone | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹75 Cr | ₹58 Cr | ₹69 Cr | ₹5,726,915 Cr | ₹56 Cr |
| Expenses | ₹67 Cr | ₹51 Cr | ₹59 Cr | ₹5,110,326 Cr | ₹50 Cr |
| Operating Profit (Excl OI) | ₹8.57 Cr | ₹6.99 Cr | ₹9.59 Cr | ₹616,589 Cr | ₹5.72 Cr |
| Other Income | ₹1.72 Cr | ₹0.82 Cr | ₹0.88 Cr | ₹84,951 Cr | ₹1.04 Cr |
| Interest | ₹0.36 Cr | ₹0.45 Cr | ₹0.64 Cr | ₹81,749 Cr | ₹1.09 Cr |
| Depreciation | ₹2.48 Cr | ₹2.45 Cr | ₹1.92 Cr | ₹186,886 Cr | ₹1.63 Cr |
| Profit Before Tax | ₹7.45 Cr | ₹5.03 Cr | ₹7.91 Cr | ₹432,906 Cr | ₹4.05 Cr |
| Profit After Tax | ₹5.58 Cr | ₹3.56 Cr | ₹5.34 Cr | ₹322,816 Cr | ₹2.84 Cr |
| Earnings Per Share (Rs) | ₹47.12 | ₹46.49 | ₹29.68 | ₹44.48 | ₹26.90 |
| PAT Margin (%) | 7.48 | 7.41 | 6.15 | 7.78 | 5.64 |
| ROE(%) | 11.72 | 12.98 | 9.23 | 15.50 | 10.59 |
| ROCE(%) | 13.61 | 16.19 | 12.26 | 20.56 | 13.25 |
| Total Debt/Equity(x) | 0.11 | 0.12 | 0.13 | 0.19 | 0.22 |
Key Financials |
||
| Market Cap | : | ₹ 113.3 Cr |
| Revenue (TTM) | : | ₹ 73.9 Cr |
| Net Profit(TTM) | : | ₹ 5.0 Cr |
| EPS (TTM) | : | ₹ 41.6 |
| P/E (TTM) | : | 22.7 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| MERCURY LABORATORIES | -3.5% | -9.4% | 19.2% |
| SUN PHARMACEUTICAL INDUSTRIES | -2.4% | -6.8% | 50.7% |
| CIPLA | -5.8% | -4% | 21% |
| DR REDDYS LABORATORIES | -4.4% | -8.6% | 14.3% |
| ZYDUS LIFESCIENCES | -1.1% | -6% | 54.5% |
| DIVIS LABORATORIES | -3.3% | -6.2% | 64.2% |
| MANKIND PHARMA | -2% | -3.9% | 37.7% |
| TORRENT PHARMACEUTICALS | -2.9% | -11.7% | 51.1% |
| LUPIN | -4.3% | -8.2% | 72.8% |
MERCURY LABORATORIES Revenues
[BOM: 538964]
| Y-o-Y | 30.06 % |
| 5 Yr CAGR | 7.93 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹75 Cr | 30.06 | |
| Mar2023 | ₹58 Cr | -15.57 | |
| Mar2022 | ₹69 Cr | -100.00 | |
| Mar2021 | ₹5,726,915 Cr | 10,314,762.99 | |
| Mar2020 | ₹56 Cr | - | |
MERCURY LABORATORIES Operating Profit
[BOM: 538964]
| Y-o-Y | 22.62 % |
| 5 Yr CAGR | 10.62 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹8.57 Cr | 22.62 | |
| Mar2023 | ₹6.99 Cr | -27.12 | |
| Mar2022 | ₹9.59 Cr | -100.00 | |
| Mar2021 | ₹616,589 Cr | 10,773,785.90 | |
| Mar2020 | ₹5.72 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | -5.72 % |
| 5 Yr CAGR | 2.50 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 11.38% | -5.72 | |
| Mar2023 | 12.07% | -13.66 | |
| Mar2022 | 13.98% | 29.81 | |
| Mar2021 | 10.77% | 4.46 | |
| Mar2020 | 10.31% | - | |
MERCURY LABORATORIES Profit After Tax
[BOM: 538964]
| Y-o-Y | 56.63 % |
| 5 Yr CAGR | 18.43 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹5.58 Cr | 56.63 | |
| Mar2023 | ₹3.56 Cr | -33.27 | |
| Mar2022 | ₹5.34 Cr | -100.00 | |
| Mar2021 | ₹322,816 Cr | 11,382,679.27 | |
| Mar2020 | ₹2.84 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | 0.94 % |
| 5 Yr CAGR | 7.31 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 7.48 % | 0.94 | |
| Mar2023 | 7.41 % | 20.49 | |
| Mar2022 | 6.15 % | -20.95 | |
| Mar2021 | 7.78 % | 37.94 | |
| Mar2020 | 5.64 % | - | |
MERCURY LABORATORIES Earnings Per Share (EPS)
[BOM: 538964]
| Y-o-Y | 1.36 % |
| 5 Yr CAGR | 15.04 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹47 | 1.36 | |
| Mar2023 | ₹46 | 56.64 | |
| Mar2022 | ₹30 | -33.27 | |
| Mar2021 | ₹44 | 65.35 | |
| Mar2020 | ₹27 | - | |
MERCURY LABORATORIES Return on Capital Employed (ROCE)
[BOM: 538964]
| Y-o-Y | -15.94 % |
| 5 Yr CAGR | 0.67 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 13.61% | -15.94 | |
| Mar2023 | 16.19% | 32.06 | |
| Mar2022 | 12.26% | -40.37 | |
| Mar2021 | 20.56% | 55.17 | |
| Mar2020 | 13.25% | - | |
MERCURY LABORATORIES Share Price vs Sensex
| Current Share Price | : | ₹944.5 |
| Current MarketCap | : | ₹ 113.3 Cr |
| Updated EOD on | : | Nov 14,2024 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MERCURY LABORATORIES | -3.5% |
-9.4% |
19.2% |
| SENSEX | -2.5% |
-5.2% |
19.5% |
MERCURY LABORATORIES related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about MERCURY LABORATORIES Financials
How the annual revenues of MERCURY LABORATORIES have changed ?
The Revenues of MERCURY LABORATORIES have increased by 30.06% YoY .
How the Earnings per Share (EPS) of MERCURY LABORATORIES have changed?
The Earnings Per Share (EPS) of MERCURY LABORATORIES has increased by 1.36 % YoY .
Check out Intrinsic Value of Peers of MERCURY LABORATORIES
Compare Stock Analytics of Peers of MERCURY LABORATORIES
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs
